Blood test hope for liver cancer diagnosis

NCT ID NCT02928627

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether two tiny molecules, called miR-221 and miR-222, can be found in the blood of people with liver cancer. Researchers wanted to see if these molecules could help diagnose the disease without needing a liver biopsy. The study was very small, with only 10 patients, and was terminated early, so the results are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could point toward a simple blood test to help diagnose or monitor liver cancer without needing a biopsy.

What could go wrong

This was a very small pilot study (only 10 participants) that was terminated early, so results are limited and may not be reliable. It is far from being a proven diagnostic tool.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fiammetta Soggiu

    Aberdeen, AB25 2ZN, United Kingdom